125 related articles for article (PubMed ID: 8731387)
1. A quantitative and qualitative analysis of prion protein immunohistochemical staining in Creutzfeldt-Jakob disease using four anti prion protein antibodies.
MacDonald ST; Sutherland K; Ironside JW
Neurodegeneration; 1996 Mar; 5(1):87-94. PubMed ID: 8731387
[TBL] [Abstract][Full Text] [Related]
2. Prion protein immunocytochemistry: reliable protocols for the investigation of Creutzfeldt-Jakob disease.
Hayward PA; Bell JE; Ironside JW
Neuropathol Appl Neurobiol; 1994 Aug; 20(4):375-83. PubMed ID: 7808588
[TBL] [Abstract][Full Text] [Related]
3. A special report I. Prion protein (PrP)--amyloid plaques in the transmissible spongiform encephalopathies, or prion diseases revisited.
Liberski PP; Bratosiewicz J; Waliś A; Kordek R; Jeffrey M; Brown P
Folia Neuropathol; 2001; 39(4):217-35. PubMed ID: 11928893
[TBL] [Abstract][Full Text] [Related]
4. Creutzfeldt-Jakob disease (CJD) of a short duration with prion protein (PrP) plaques.
Liberski PP; Kwieciński H; Barcikowska M; Mirecka B; Kulczycki J; Kida E; Brown P; Gajdusek DC
Patol Pol; 1991; 42(4):115-8. PubMed ID: 1845486
[TBL] [Abstract][Full Text] [Related]
5. Positive transmission of Creutzfeldt-Jakob disease verified by murine kuru plaques.
Kitamoto T; Tateishi J; Sawa H; Doh-Ura K
Lab Invest; 1989 Apr; 60(4):507-12. PubMed ID: 2468821
[TBL] [Abstract][Full Text] [Related]
6. Prion protein immunoreactivity in brain samples from an unselected autopsy population: findings in 200 consecutive cases.
Esiri MM; Carter J; Ironside JW
Neuropathol Appl Neurobiol; 2000 Jun; 26(3):273-84. PubMed ID: 10886685
[TBL] [Abstract][Full Text] [Related]
7. Prion protein deposition and abnormal synaptic protein expression in the cerebellum in Creutzfeldt-Jakob disease.
Ferrer I; Puig B; Blanco R; Martí E
Neuroscience; 2000; 97(4):715-26. PubMed ID: 10842016
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical localization of prion protein in spongiform encephalopathies and normal brain tissue.
Piccardo P; Safar J; Ceroni M; Gajdusek DC; Gibbs CJ
Neurology; 1990 Mar; 40(3 Pt 1):518-22. PubMed ID: 1690364
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical verification of senile and kuru plaques in Creutzfeldt-Jakob disease and the allied disease.
Kitamoto T; Tateishi J; Sato Y
Ann Neurol; 1988 Oct; 24(4):537-42. PubMed ID: 3071243
[TBL] [Abstract][Full Text] [Related]
10. Reactive microglia in Creutzfeldt-Jakob disease.
Mühleisen H; Gehrmann J; Meyermann R
Neuropathol Appl Neurobiol; 1995 Dec; 21(6):505-17. PubMed ID: 8745240
[TBL] [Abstract][Full Text] [Related]
11. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease.
Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I
Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804
[TBL] [Abstract][Full Text] [Related]
12. Sporadic Creutzfeldt-Jakob disease with MM1-type prion protein and plaques.
Ishida C; Kakishima A; Okino S; Furukawa Y; Kano M; Oda Y; Nakanishi I; Makifuchi T; Kitamoto T; Yamada M
Neurology; 2003 Feb; 60(3):514-7. PubMed ID: 12578942
[TBL] [Abstract][Full Text] [Related]
13. Brain biopsy in Creutzfeldt-Jakob disease: evolution of pathological changes by prion protein immunohistochemistry.
Mahadevan A; Shankar SK; Yasha TC; Santosh V; Sarkar C; Desai AP; Satishchandra P
Neuropathol Appl Neurobiol; 2002 Aug; 28(4):314-24. PubMed ID: 12175344
[TBL] [Abstract][Full Text] [Related]
14. Deposition of the prion protein (PrP) during the evolution of experimental Creutzfeldt-Jakob disease.
Kordek R; Hainfellner JA; Liberski PP; Budka H
Acta Neuropathol; 1999 Dec; 98(6):597-602. PubMed ID: 10603035
[TBL] [Abstract][Full Text] [Related]
15. Creutzfeldt-Jakob disease.
Sikorska B; Knight R; Ironside JW; Liberski PP
Adv Exp Med Biol; 2012; 724():76-90. PubMed ID: 22411235
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of water channel aquaporin 1 and aquaporin 4 in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP transgenic mice.
Rodríguez A; Pérez-Gracia E; Espinosa JC; Pumarola M; Torres JM; Ferrer I
Acta Neuropathol; 2006 Nov; 112(5):573-85. PubMed ID: 16871401
[TBL] [Abstract][Full Text] [Related]
17. Neuronal and astrocytic responses involving the serotonergic system in human spongiform encephalopathies.
Fraser E; McDonagh AM; Head M; Bishop M; Ironside JW; Mann DM
Neuropathol Appl Neurobiol; 2003 Oct; 29(5):482-95. PubMed ID: 14507340
[TBL] [Abstract][Full Text] [Related]
18. Neuropathological diagnostic criteria for Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases).
Budka H; Aguzzi A; Brown P; Brucher JM; Bugiani O; Gullotta F; Haltia M; Hauw JJ; Ironside JW; Jellinger K
Brain Pathol; 1995 Oct; 5(4):459-66. PubMed ID: 8974629
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical localization of 14.3.3 zeta protein in amyloid plaques in human spongiform encephalopathies.
Richard M; Biacabe AG; Streichenberger N; Ironside JW; Mohr M; Kopp N; Perret-Liaudet A
Acta Neuropathol; 2003 Mar; 105(3):296-302. PubMed ID: 12557018
[TBL] [Abstract][Full Text] [Related]
20. An autopsied case of Creutzfeldt-Jakob disease with mutation in the prion protein gene codon 232 and type 1+2 prion protein.
Iwasaki Y; Yokoi F; Tatsumi S; Mimuro M; Iwai K; Kitamoto T; Yoshida M
Neuropathology; 2013 Oct; 33(5):568-75. PubMed ID: 23320809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
